Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia-Reference-Cited by-同舟云学术

Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia

Published:2009-04-27 Issue:5 Volume:15 Page:504-508
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Almutairi Fawaz,Peterson Theresa C.,Molinari Michele,Walsh Mark J.,Alwayn Ian,Peltekian Kevork M.

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.21710/fullpdf

Reference31 articles.

1. Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin;Imagawa;Transplantation,1996

2. Hyperlipidemia and other coronary risk factors after orthotopic liver transplantation: pathogenesis, diagnosis and management;Munoz;Liver Transpl Surg,1995

3. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events;Laryea;Liver Transpl,2007

4. Reducing the risks of cardiovascular disease in liver allograft recipients;Mells;Transplantation,2007

5. Effect of atorvastatin on cyclosporine pharmacokinetics in liver transplant recipients;Taylor;Ann Pharmacother,2004

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-Liver Transplant Metabolic Syndrome;Journal of Clinical and Experimental Hepatology;2024-07

2. Metabolic Disorders in Liver Transplant Recipients: The State of the Art;Journal of Clinical Medicine;2024-02-09

3. Special Patient Populations;Clinical Lipidology;2024

4. Minimizing Metabolic and Cardiac Risk Factors to Maximize Outcomes After Liver Transplantation;Transplantation;2023-12-07

5. Long Term Complications of Immunosuppression Post Liver Transplant;Journal of Clinical and Experimental Hepatology;2023-11